Allgens(SH:688613) Xin Lang Cai Jing·2025-09-23 23:55Group 1 - The core point of the news is that BioVeda China RMB Investment Limited has reduced its shareholding in Aojing Medical Technology Co., Ltd., bringing its stake below 5% [18][19][23] - The shareholding before the reduction was 7,239,358 shares, accounting for 5.28% of the total shares [8] - After the reduction, BioVeda holds 6,850,430 shares, which is 5% of the total shares [9][10] Group 2 - The reduction was executed through block trading and centralized bidding on the Shanghai Stock Exchange [7][10] - The total number of shares reduced was 388,928, representing 0.28% of the total shares [20] - BioVeda has stated that it may continue to reduce its holdings in the next 12 months, adhering to relevant legal disclosure obligations [6][23] Group 3 - The reduction does not trigger a mandatory tender offer and will not change the controlling shareholder or actual controller of Aojing Medical [18][23] - BioVeda has confirmed that there are no restrictions on the rights of the shares held, such as pledges or freezes [11] - The company has complied with all relevant laws and regulations regarding the share reduction [20][33]